HUP0002455A2 - Gyomorban maradó gyógyszerészeti készítmény - Google Patents

Gyomorban maradó gyógyszerészeti készítmény

Info

Publication number
HUP0002455A2
HUP0002455A2 HU0002455A HUP0002455A HUP0002455A2 HU P0002455 A2 HUP0002455 A2 HU P0002455A2 HU 0002455 A HU0002455 A HU 0002455A HU P0002455 A HUP0002455 A HU P0002455A HU P0002455 A2 HUP0002455 A2 HU P0002455A2
Authority
HU
Hungary
Prior art keywords
gastric
pharmaceutical composition
carbon dioxide
retained
generating system
Prior art date
Application number
HU0002455A
Other languages
English (en)
Inventor
Jérome Besse
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of HUP0002455A2 publication Critical patent/HUP0002455A2/hu
Publication of HUP0002455A3 publication Critical patent/HUP0002455A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya gyomorban maradó gyógyszerkészítmény, amely azalábbi komponenseket tartalmazza: (a) hatóanyag, amely benzamid vagybenzamidsó, (b) szén-dioxid-fejlesztő rendszer, és (c) valamelyeszköz, amely lehetővé teszi a szén-dioxid-generáló rendszer általfejlesztett szén-dioxid részleges visszatartását. Ó
HU0002455A 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition HUP0002455A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique

Publications (2)

Publication Number Publication Date
HUP0002455A2 true HUP0002455A2 (hu) 2000-12-28
HUP0002455A3 HUP0002455A3 (en) 2001-01-29

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002455A HUP0002455A3 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition

Country Status (19)

Country Link
EP (1) EP0983065A1 (hu)
JP (1) JP2001523241A (hu)
KR (1) KR20010006353A (hu)
CN (1) CN1252720A (hu)
AR (1) AR015586A1 (hu)
AU (1) AU737634B2 (hu)
CA (1) CA2286081A1 (hu)
FR (1) FR2762213B1 (hu)
HU (1) HUP0002455A3 (hu)
IL (1) IL131995A0 (hu)
JO (1) JO2017B1 (hu)
MA (1) MA26482A1 (hu)
NO (1) NO995039L (hu)
NZ (1) NZ500288A (hu)
PE (1) PE68199A1 (hu)
PL (1) PL336273A1 (hu)
TN (1) TNSN98049A1 (hu)
WO (1) WO1998047506A1 (hu)
ZA (1) ZA983258B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2009157711A2 (ko) * 2008-06-24 2009-12-30 Park Eun-Seok 위장체류형 다공성 정제 및 그의 제조 방법
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
SI2719376T1 (sl) 2012-10-12 2015-06-30 Omya International Ag Gastrointestinalna zdravilna formulacija in razdeljevalni sistem in njen naäśin priprave z uporabo funkcionaliziranega kalcijevega karbonata
SG11202005016SA (en) 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
JP7044649B2 (ja) * 2018-06-28 2022-03-30 株式会社ファンケル 胃内浮遊錠剤
KR20220018004A (ko) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 조절 방출 제형 및 이의 용도
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials

Also Published As

Publication number Publication date
AU737634B2 (en) 2001-08-23
PL336273A1 (en) 2000-06-19
NZ500288A (en) 2001-03-30
AR015586A1 (es) 2001-05-16
FR2762213A1 (fr) 1998-10-23
AU7341698A (en) 1998-11-13
NO995039D0 (no) 1999-10-15
NO995039L (no) 1999-12-17
HUP0002455A3 (en) 2001-01-29
WO1998047506A1 (fr) 1998-10-29
MA26482A1 (fr) 2004-12-20
JO2017B1 (en) 1999-05-15
TNSN98049A1 (fr) 2005-03-15
PE68199A1 (es) 1999-07-15
CN1252720A (zh) 2000-05-10
KR20010006353A (ko) 2001-01-26
EP0983065A1 (fr) 2000-03-08
IL131995A0 (en) 2001-03-19
JP2001523241A (ja) 2001-11-20
FR2762213B1 (fr) 1999-05-14
ZA983258B (en) 1998-10-19
CA2286081A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
HUP0103925A2 (hu) Formoterolt tartalmazó, stabilan tárolható hatóanyag-koncentrátum
HUP0002455A2 (hu) Gyomorban maradó gyógyszerészeti készítmény
DK1123120T3 (da) Medicinsk aerosolformulering
TR200002812T2 (tr) Efervesan formülasyonları.
RU95101387A (ru) Концентрированный водный раствор аргатробана
HUP9802999A2 (hu) N-propargil-1-amino-indánt tartalmazó gyógyszerkészítmény
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
NZ502280A (en) Combination therapy comprising atorvastatin and an antihypertensive agent
HUP0301972A2 (hu) Fentanilszerű szerkezetű opioidot és ketamint tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
ES2158494T3 (es) Caramelos que contienen un edulcorante.
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
HUP9801227A2 (hu) Monoamin-oxidáz B inhibitorokból álló gyógyászati készítmények és alkalmazásuk
RS50165B (sr) Primena rar selektivnih retinoid antagonista za proizvodnju leka za tretiranje emfizema
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
HUP0202324A2 (hu) Prukaloprid orális oldat
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
ATE28188T1 (de) Antikonvulsive mittel.
HUP0302738A2 (hu) SARP-1 alkalmazása scleroderma kezelésére és megelőzésére
DE3879985D1 (de) Anticonvulsive agenzien.
SE9604752D0 (sv) Formulation and use
PH23173A (en) P-acylaminobenzamides
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
HUP9904178A2 (hu) 4-Bróm-1-metil-5-trifluor-metil-3-(2-fluor-4-klór-5-izopropoxi-karbonil-fenil)-pirazol alapú herbicid készítmények
NO883987D0 (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.